Recent advances in the diagnosis and treatment of Coats' disease
- PMID: 30895419
- DOI: 10.1007/s10792-019-01095-8
Recent advances in the diagnosis and treatment of Coats' disease
Abstract
Purpose: To review and summarize the recent progress in the diagnosis and treatment of Coats' disease.
Methods: Literature was collected from Web of Science, Medline and Pubmed, through searching of these keywords: "Coats' disease", "diagnosis" and "treatment".
Results: Coats' disease is characterized by idiopathic leaky retinal vascular telangiectasia and microvascular abnormalities often accompanied by intraretinal or subretinal exudation and retinal detachment. Neovascular glaucoma and phthisis bulbi often occur in advanced cases. Coats' disease has significant diversity in terms of its clinical presentation and morphology. Anti-VEGF therapy combined with laser photocoagulation for early Coats' disease and anti-VEGF therapy combined with minimally invasive vitrectomy for advanced Coats' disease can achieve good efficacy.
Conclusion: Early diagnosis and timely treatment based on clinical stage are critical to retaining the patient's visual function. Patients should be aware that close long-term follow-up is necessary.
Keywords: Coats’ disease; Diagnosis; Treatment; VEGF.
Similar articles
-
Lifting the White Walker's curse-Management of Coats' disease.Indian J Ophthalmol. 2023 Aug;71(8):3117. doi: 10.4103/IJO.IJO_777_23. Indian J Ophthalmol. 2023. PMID: 37530299 Free PMC article.
-
Coats' Disease: A Comprehensive Review of Its Pathophysiology, Diagnosis, and Advances in Treatment.Semin Ophthalmol. 2025 Aug;40(6):458-473. doi: 10.1080/08820538.2024.2447965. Epub 2024 Dec 30. Semin Ophthalmol. 2025. PMID: 40094375 Review.
-
Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.Br J Ophthalmol. 2012 Mar;96(3):356-9. doi: 10.1136/bjophthalmol-2011-300141. Epub 2011 Jun 7. Br J Ophthalmol. 2012. PMID: 21653215
-
[Adjuvant anti-VEGF therapy in Coats' disease].Ophthalmologe. 2015 May;112(5):451-4. doi: 10.1007/s00347-014-3122-0. Ophthalmologe. 2015. PMID: 25134462 German.
-
Diagnosis and treatment of coats' disease: a review of the literature.Ophthalmologica. 2012;227(4):175-82. doi: 10.1159/000336906. Epub 2012 Mar 20. Ophthalmologica. 2012. PMID: 22440929 Review.
Cited by
-
Fovea-threatening and fovea-involving peripheral Coats disease: effects of posture and intervention.Int J Retina Vitreous. 2022 Jun 17;8(1):42. doi: 10.1186/s40942-022-00382-4. Int J Retina Vitreous. 2022. PMID: 35715849 Free PMC article.
-
Late presentation of Coats disease in a 12-year-old boy: a case report.Pan Afr Med J. 2024 Oct 11;49:36. doi: 10.11604/pamj.2024.49.36.45134. eCollection 2024. Pan Afr Med J. 2024. PMID: 39886112 Free PMC article.
-
Experience with Intravitreal Ranibizumab as an Adjunct to Ablation Therapy in Eyes with Exudative Coats' Disease.Clin Ophthalmol. 2021 Jan 29;15:367-373. doi: 10.2147/OPTH.S293030. eCollection 2021. Clin Ophthalmol. 2021. PMID: 33542620 Free PMC article.
-
Place of dexamethasone implant as an adjunctive treatment in Coats' disease: a retrospective single-center study.BMC Ophthalmol. 2025 Jul 29;25(1):435. doi: 10.1186/s12886-025-04279-2. BMC Ophthalmol. 2025. PMID: 40731271 Free PMC article.
-
Multimodal imaging diagnosis and analysis of prognostic factors in patients with adult-onset Coats disease.Int J Ophthalmol. 2024 Aug 18;17(8):1469-1476. doi: 10.18240/ijo.2024.08.12. eCollection 2024. Int J Ophthalmol. 2024. PMID: 39156792 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources